Results 111 to 120 of about 130,862 (133)

QT-prolonging medications: prevalence of use and associated risks in CKD. [PDF]

open access: yesNephrol Dial Transplant
Liabeuf S   +7 more
europepmc   +1 more source

Utilizing nitrogen, sulfur, phosphorus, and chlorine co-doped carbon dots as a fluorescent probe for determination of vancomycin in exhaled breath condensate. [PDF]

open access: yesHeliyon
Shirazi K   +7 more
europepmc   +1 more source

Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.

open access: yesJournal of Pharmacy and Pharmacology, 2016
Objectives The aim of this work was to investigate the use of liquisolid technique to sustain the release of a model highly soluble drug, diltiazem HCl, from liquisolid matrices containing Polyox, a recently proposed matrix-forming hydrophilic polymer as
Kofi Asare-Addo   +2 more
exaly   +3 more sources

Development and release mechanism of diltiazem HCl prolonged release matrix tablets

open access: yesDrug Delivery, 2009
A coated matrix tablet formulation has been used to develop controlled release diltiazem HCl (DIL) tablets. The developed drug delivery system provided prolonged drug release rates over a defined period of time.
Dennis Douroumis
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Long-acting diltiazem HCL for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris

Expert Opinion on Pharmacotherapy, 2005
Stephen P. Glasser, Steven A Claas
exaly  

Formulation of Sustained-Release Verapamil HCl and Diltiazem HCl Semisolid Matrix Capsules

Pharmaceutical Development and Technology, 2008
Chien Ngoc Nguyen   +2 more
exaly  

Home - About - Disclaimer - Privacy